Cryo-Cell Price to Sales Ratio 2010-2024 | CCEL
Historical PS ratio values for Cryo-Cell (CCEL) over the last 10 years. The current P/S ratio for Cryo-Cell as of May 16, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cryo-Cell P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-16 | 9.13 | 2.43 | |
| 2024-02-29 | 5.20 | $3.76 | 1.38 |
| 2023-11-30 | 5.35 | $3.74 | 1.43 |
| 2023-08-31 | 6.00 | $3.71 | 1.61 |
| 2023-05-31 | 4.85 | $3.69 | 1.32 |
| 2023-02-28 | 3.82 | $3.64 | 1.05 |
| 2022-11-30 | 4.37 | $3.55 | 1.23 |
| 2022-08-31 | 6.53 | $3.51 | 1.86 |
| 2022-05-31 | 5.43 | $3.46 | 1.57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.076B | $0.031B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.503B | 15.75 |
| Cencora (COR) | United States | $44.240B | 17.25 |
| ICON (ICLR) | Ireland | $26.547B | 25.06 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Avantor (AVTR) | United States | $17.124B | 25.21 |
| CochLear (CHEOY) | Australia | $14.770B | 0.00 |
| Revvity (RVTY) | United States | $13.241B | 23.23 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.178B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.576B | 41.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.562B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 22.93 |
| Solventum (SOLV) | United States | $10.784B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.508B | 48.62 |
| Organon (OGN) | United States | $5.568B | 5.28 |
| Bausch + Lomb (BLCO) | Canada | $5.269B | 21.11 |
| Doximity (DOCS) | United States | $4.449B | 33.12 |
| PACS (PACS) | United States | $4.257B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.440B | 31.48 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $2.979B | 31.21 |
| GoodRx Holdings (GDRX) | United States | $2.728B | 103.86 |
| Progyny (PGNY) | United States | $2.550B | 43.90 |
| Premier (PINC) | United States | $2.383B | 8.92 |
| AMN Healthcare Services Inc (AMN) | United States | $2.287B | 9.06 |
| NovoCure (NVCR) | Jersey | $2.265B | 0.00 |
| Agilon Health (AGL) | United States | $2.180B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.992B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.647B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.348B | 0.00 |
| Embecta (EMBC) | United States | $0.793B | 5.39 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.690B | 7.32 |
| Auna S.A (AUNA) | Luxembourg | $0.648B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.566B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.434B | 43.30 |
| MultiPlan (MPLN) | United States | $0.405B | 0.00 |
| ModivCare (MODV) | United States | $0.382B | 7.15 |
| LifeMD (LFMD) | United States | $0.351B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 18.67 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| Sharecare (SHCR) | United States | $0.275B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.124B | 41.67 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| Oncology Institute (TOI) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |